Interleukin-6 and its soluble receptor during acute meningococcal infections
- 1 November 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 24 (11) , 1801-1805
- https://doi.org/10.1097/00003246-199611000-00007
Abstract
To determine the pattern of the soluble interleukin (IL)-6 receptor during acute meningococcal infections and recovery phase, and to measure the effect of plasma or whole blood exchange on the plasma concentrations of these mediators. Prospective, descriptive patient study. University hospital intensive care unit. Patients with bacteriologically proven meningococcal infections were entered in the study. Three group were formed: a) patients with meningitis without shock (group A); b) patients with meningitis and shock (group B); and c) patients with shock only (group C). Part (n = 9) of the patients with shock underwent plasma or whole blood exchange. Serum concentrations of interleukin-6 and soluble IL-6 receptors were determined sequentially during the acute and recovery phases. Peak concentrations of IL-6 were highest in group C, followed by group B and group A. Soluble IL-6 receptor concentrations showed an opposite pattern and were all below normal. Soluble IL-6 receptor concentrations were negatively correlated with the IL-6 concentrations. During recovery, IL-6 rapidly decreased and soluble IL-6 receptors increased to supranormal concentrations, after which concentrations returned to normal. Plasma or whole blood exchange did not significantly influence IL-6 concentrations but did increase the soluble IL-6 receptor concentration directly after an exchange session followed by a rapid decrease. Soluble IL-6 receptor concentrations are low in acute meningococcal infections. Plasma or whole blood exchange temporarily increases these concentrations. It needs to be determined whether the effect of this therapy is beneficial to the patient.Keywords
This publication has 18 references indexed in Scilit:
- Circulating Interleukin-6 Receptor in Patients with Sepsis SyndromeThe Journal of Infectious Diseases, 1995
- Regulation of interleukin‐6 receptor expression by interleukin‐6 in human monocytes — a re‐examinationFEBS Letters, 1994
- Regulation of interleukin-6 receptor expression in rat Kupffer cells: modulation by cytokines, dexamethasone and prostaglandin E2Journal of Hepatology, 1994
- EFFECTS OF RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR (TNFRCritical Care Medicine, 1994
- The soluble interleukin‐6 receptor is generated by sheddingEuropean Journal of Immunology, 1993
- Plasma and Whole Blood Exchange in Meningococcal SepsisClinical Infectious Diseases, 1992
- Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptorCytokine, 1992
- Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.The Journal of Experimental Medicine, 1992
- Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.The Journal of Experimental Medicine, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989